August 27, 2014 3:46 PM ET


Company Overview of Mallinckrodt LLC

Company Overview

Mallinckrodt LLC manufactures and distributes products used in diagnostic procedures, and in the treatment of pain and related conditions. It offers addiction treatment products, and specialty generics and pharmaceuticals; and active pharmaceutical ingredients, including medicinal narcotics, acetaminophen/paracetamol, stearates, phosphates, and peptides, as well as analytical research samples for pharmaceutical companies and analytical laboratories. The company also supplies medical isotope technetium-99m; and radiopharmaceuticals, and contrast media and delivery systems. It serves customers in the United States and internationally. The company was founded in 1867 and is based in St. Louis, ...

675 McDonnell Boulevard

St. Louis, MO 63042

United States

Founded in 1867





Key Executives for Mallinckrodt LLC

Mallinckrodt LLC does not have any Key Executives recorded.

Mallinckrodt LLC Key Developments

IGI, Laboratories, Inc. Enters into Non-Exclusive License with Mallinckrodt LLC and Nuvo Research Inc

IGI Laboratories Inc. announced that it has entered into an agreement with Mallinckrodt LLC, Mallinckrodt Inc., and Nuvo Research Inc. to settle a declaratory judgment action brought by IGI, concerning IGI's filing of an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to market a generic version of PENNSAID (diclofenac sodium topical solution) 1.5% w/w. Under the terms of this agreement, Mallinckrodt granted IGI a non-exclusive license to launch its diclofenac sodium topical solution 1.5% product on March 28, 2015. IGI received tentative approval of its diclofenac sodium topical solution 1.5% from the FDA on May 7, 2014.

Mallinckrodt Pharmaceuticals Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014 04:45 PM

Mallinckrodt Pharmaceuticals Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014 04:45 PM. Venue: Kempinski Hotel Suzhou, Suzhou, China.

Nuvo Research Inc. Announces Lawsuit Against Mallinckrodt

Nuvo Research Inc. announced that the company has commenced legal action against Mallinckrodt Inc. (Mallinckrodt) by filing a Complaint in the United States District Court for the Southern District of New York. The complaint asserts that Mallinckrodt has breached its contractual obligations to Nuvo as set out in a Licensing Agreement dated June 15, 2009 pursuant to which Nuvo licensed to Mallinckrodt the rights to market and sell Pennsaid and Pennsaid 2% in the United States. The complaint asserts that Mallinckrodt breached the license agreement in several respects. Most significantly, Mallinckrodt willfully failed to conduct certain clinical studies required under the contract that are critical to regulatory approval, marketing and sales of Pennsaid 2% throughout the world. The complaint also alleges, amongst other things, that Mallinckrodt made significant errors in certain clinical studies for which it was responsible, failed to apply requisite efforts to commercialize Pennsaid in the United States and has willfully refused to pay the full milestone payments due to Nuvo under the license agreement. Nuvo is seeking damages of not less than $100 million and a declaration that it is entitled to terminate the license agreement which would result in the rights to market and sell Pennsaid and/or Pennsaid 2% in the United States reverting to Nuvo. Nuvo has not terminated the license agreement which continues in accordance with its terms pending the court's decision.

Similar Private Companies By Industry

Company Name Region
Standard Homeopathic Company United States
Social Psychiatry Research Institute United States
Salix Pharmaceuticals, Inc. United States
Troy Manufacturing Inc. United States
Celsis Laboratory Group (New Jersey) Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mallinckrodt LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at